RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 701–800 of 1,009
Chemical Mediators of Migraine: Preclinical and Clinical Observations
Gupta, S. K., Nahas, S. J., & Peterlin, B. L. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01929.x · Cited by 46
“RAMP1 endows the receptor with the specificity for CGRP (other RAMP members, such as RAMP2 and RAMP3, form complexes with CLR, which result in the adrenomedullin receptors 1 and 2, respectively).(77) RAMP1 also promotes the expression of CLR receptors on the cell membrane, as well as determines the selectivity of CGRP…”
BackgroundRegulation of appetite to treat obesity
Kim, G. W., Lin, J. E., Valentino, M. A., Colón‐González, F., & Waldman, S. A. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.3 · Cited by 56
Vohra, S., Taddese, B., Conner, A. C., Poyner, D. R., Hay, D. L., Barwell, J., Reeves, P. J., UPTON, G. J. G., & Reynolds, C. A. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0846 · Cited by 46
“RAMPs regulate the transport and ligand specificity of the CLR [19].”
BackgroundSpecific TBC Domain-Containing Proteins Control the ER-Golgi-Plasma Membrane Trafficking of GPCRs
Wei, Z., Zhang, M., Li, C., Huang, W. Y., Fan, Y., Guo, J., Khater, M., Fukuda, M., Dong, Z., Hu, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.033 · Cited by 46
“, 2011), receptor activity modifying proteins, chaperones, escort proteins, gatekeepers, protein kinases, and small GTPases (Chen et al., 2009; Colley et al., 1991; Doly et al., 2016; Dwyer etal., 1998; Ferreira et al., 1996; Hay and Pioszak, 2016; McLatchie et al., 1998; Sauvageau et al., 2014; Shiwarski et al., 2017…”
BackgroundInfluentialAdrenomedullin expression in rat uterus is correlated with plasma estradiol
Cameron, V. A., Autelitano, D. J., Evans, J. J., Ellmers, L. J., Espiner, E. A., Nicholls, M. G., & Richards, M. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e139 · Cited by 48
“When RAMP2 transported the CRLR to the cell surface, the complex was shown to act as a specific AM receptor (25).”
BackgroundKoth, C. M., Abdul-Manan, N., Lepre, C. A., Connolly, P. J., Yoo, S., Mohanty, A. K., Lippke, J. A., Zwahlen, J., Coll, J. T., Doran, J., et al. (2010) · Biochemistry · doi:10.1021/bi901848m · Cited by 46
Jones, S. W., Brockbank, S., Mobbs, M., Good, N. L., Soma-Haddrick, S., Heuze, A. J., Langham, C., Timms, D. A., Newham, P., & Needham, M. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.01.007 · Cited by 46
Progesterone induction of calcitonin expression in the murine mammary gland
Ismail, P., DeMayo, F. J., Amato, P., & Lydon, J. P. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800287 · Cited by 48
“Moreover, with the emergence of receptor-activity modifying proteins (McLatchie et al. 1998, Christopoulos et al. 1999, Sexton et al. 2001), the possibility that mammary CTR may project all or part of its downstream effects independently of CT ligand must be considered, especially in light of the…”
BackgroundG Protein-Coupled Receptors in Invertebrates: A State of the Art
Meeusen, T., Mertens, I., LOOF, A. D., & Schoofs, L. (2003) · International review of cytology · doi:10.1016/s0074-7696(03)30004-x · Cited by 46
Adrenomedullin: a Possible Autocrine or Paracrine Hormone in the Cardiac Ventricles
KATO, J., TSURUDA, T., KITAMURA, K., & ETO, T. (2003) · Hypertension Research · doi:10.1291/hypres.26.s113 · Cited by 47
“CRLR coexpressed with RAMP-1 serves as a calcitonin gene-related peptide (CGRP) receptor, while it functions as an AM receptor when coexpressed with either RAMP-2 or 3 (49).”
BackgroundFunctional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806
Nunn, C., Schoeffter, P., Langenegger, D., & Hoyer, D. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0656-5 · Cited by 46
“differences in G-protein repertoire, signalling isoenzymes, post-translational receptor modification, presence or absence of G-protein signalling (RGS) proteins and expression of receptor-activity modifying proteins (RAMPS); Lefkowitz et al. 1993; Heximer et al. 1997; Kaupmann et al. 1998; McLatchie et al. 1998; De Vr…”
BackgroundSiehler, S., & Hoyer, D. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900144 · Cited by 46
Dumont, Y., Chabot, J., & Quirion, R. (2004) · Peptides · doi:10.1016/j.peptides.2004.01.013 · Cited by 49
Roth, J. D. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835b896f · Cited by 45
“The amylin receptor complex was described in vitro more than a decade ago [6].”
BackgroundInfluentialDi/Oligomerization of GPCRs—Mechanisms and Functional Significance
Rivero‐Müller, A., Jonas, K., Hanyaloglu, A. C., & Huhtaniemi, I. T. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386931-9.00007-6 · Cited by 47
Transcriptome sequencing supports a conservation of macrophage polarization in fish
Wentzel, A. S., Petit, J., van Veen, W. G., Fink, I. R., Scheer, M. H., Piazzon, M. C., Forlenza, M., Spaink, H. P., & Wiegertjes, G. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-70248-y · Cited by 52
Ouafik, L., Berenguer‐Daizé, C., & Berthois, Y. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.001 · Cited by 46
Haploinsufficiency for Adrenomedullin Reduces Pinopodes and Diminishes Uterine Receptivity in Mice1
Li, M., Wu, Y., & Caron, K. M. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.069336 · Cited by 45
“Nevertheless, the identification and functional validation of a conserved signaling paradigm involving AM, CL, and RAMP2 in uterine epithelial cells and stroma offers a unique and pharmacologically tractable system for potentially modulating uterine receptivity.”
BackgroundInfluentialLang, M., Pol, S. D., Baldauf, C., Hofmann, H., Reiser, O., & Beck‐Sickinger, A. G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050613s · Cited by 45
Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction
Hamid, S. A., & Baxter, G. F. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.012 · Cited by 49
Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension
Cases, A., Esforzado, N., Lario, S., Vera, M., Lopez-Pedret, J., Rivera‐Fillat, F., & Jiménez, W. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00888.x · Cited by 48
Kadmiel, M., Fritz-Six, K., Pacharne, S., Richards, G. O., Li, M., Skerry, T. M., & Caron, K. M. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0400 · Cited by 44
Immunomodulatory Role of Neuropeptides in the Cornea
Puri, S., Kenyon, B. M., & Hamrah, P. (2022) · Biomedicines · doi:10.3390/biomedicines10081985 · Cited by 44
RAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis
Tsuru, S., Ito, Y., Matsuda, H., Hosono, K., Inoue, T., Nakamoto, S., Kurashige, C., Mishima, T., Tsujikawa, K., Okamoto, H., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-019-0364-0 · Cited by 46
Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells
Shichiri, M., Fukai, N., Ozawa, N., Iwasaki, H., & Hirata, Y. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00036-3 · Cited by 46
Orexins/hypocretins and orexin receptors in apoptosis: a mini‐review
Laburthe, M., Voisin, T., & Firar, A. E. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02035.x · Cited by 46
“Such differences could be tentatively ascribed to the cellular context of receptor expression as suggested for other GPCRs the selectivity of which is driven by accessory proteins such as the receptor activity modifying proteins RAMPs (McLatchie et al. 1998, Christopoulos et al. 2003).”
BackgroundStructural and compositional determinants of cortistatin activity
Criado, J. R., Li, H., Jiang, X., Spina, M. G., Huitrón‐Reséndiz, S., Liapakis, G., Calbet, M., Siehler, S., Henriksen, S. J., Koob, G. K., et al. (1999) · Journal of Neuroscience Research · Cited by 44
Wisskirchen, F. M., Gray, D. W., & Marshall, I. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702764 · Cited by 44
“Part of this range may re¯ect di erences in CRLR (calcitonin receptor like receptor) and the accessory protein RAMP, the combination of these two being required for a functional CGRP receptor (McLatchie et al., 1998).”
BackgroundThe Role of Adrenomedullin in Producing Differential Hemodynamic Responses during Sepsis
Koo, D. J., Zhou, M., Chaudry, I. H., & Wang, P. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2000.6013 · Cited by 46
RAMPs and CRLR expressions in osteoblastic cells after dexamethasone treatment
Uzan, B., de Vernejoul, M.-C., & Cressent, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.037 · Cited by 43
Migraine Genes and the Relation to Gender
Shyti, R., de Vries, B., & van den Maagdenberg, A. (2011) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01913.x · Cited by 44
“RAMP1 is a transmembrane subunit necessary for functioning of calcitonin gene-related protein (CGRP) receptor.(73) CGRP has long been recognized as a key factor implicated in migraine pathophysiology.”
BackgroundDuvernay, M. T., Wang, H., Dong, C., Guidry, J. J., Sackett, D. L., & Wu, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.222323 · Cited by 43
Regulation of pancreatic physiology by adrenomedullin and its binding protein
Zudaire, E., Cuttitta, F. F., & Martínez, A. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00030-2 · Cited by 54
“The ligand specificity of this receptor is regulated by members of a group of single transmembrane domain proteins named receptor activity-modifying proteins (RAMPs) [ 50 ].”
BackgroundLafont, A.-G., Wang, Y.-F., Chen, G.-D., Liao, B., Tseng, Y., Huang, C., & Hwang, P. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.301 · Cited by 50
“In mammals, CT receptor (CTR) and CT receptor–like receptor (CRLR) share high sequence identity and form specific receptors to this family when combined with selective receptor activity–modifying proteins (RAMPs).((24)) The association of CTR and CRLR with three different RAMPs determines the ligand specificity of the…”
BackgroundPérez‐Castells, J., Martín‐Santamaría, S., Nieto, L., Ramos, A., Martínez, A., de Pascual‐Teresa, B., & Jiménez‐Barbero, J. (2011) · Biopolymers · doi:10.1002/bip.21700 · Cited by 43
h CALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia
Mackie, D. I., Mutairi, F. A., Davis, R. B., Kechele, D. O., Nielsen, N. R., Snyder, J. C., Caron, M. G., Kliman, H. J., Berg, J. S., Simms, J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180528 · Cited by 43
“, 2015, 2017) to screen for cellular cotranslocation of hCLR– hRAMP heterodimer complexes to the cell surface, exploiting the fact that the forward trafficking of either hCLR or hRAMPs from the Golgi to the plasma membrane are mutually interdependent (McLatchie et al., 1998; Hay et al., 2006).”
Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential
Fischer, J., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2020) · Peptides · doi:10.1016/j.peptides.2020.170347 · Cited by 44
Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients
Ochoa‐Callejero, L., García-Sanmartín, J., Villoslada-Blanco, P., Íñiguez, M., Pérez‐Matute, P., Pujadas, E., Fowkes, M. E., Brody, R., Oteo, J. A., & Martínez, A. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa199 · Cited by 43
“Among those markers, we were especially interested in receptor activity modifying protein 1 (RAMP1) which, in combination with the calcitonin receptor-like receptor (CLR), constitutes the receptor for calcitonin gene-related peptide (CGRP) [7].”
Sensory-Nerve-Derived Neuropeptides: Possible Therapeutic Targets
Fernandes, E. S., Schmidhuber, S. M., & Brain, S. D. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-79090-7_11 · Cited by 44
“spanning receptor activity modifying protein (RAMP;McLatchie et al. 1998).”
BackgroundMaximizing serendipity: strategies for identifying ligands for orphan G-protein-coupled receptors
Robas, N. M., O’Reilly, M., Katugampola, S., & Fidock, M. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00010-9 · Cited by 43
Adrenomedullin, an Autocrine Mediator of Blood-Brain Barrier Function
Kis, B., Ábrahám, C. S., Deli, M. A., Kobayashi, H., Niwa, M., Yamashita, H., Busija, D. W., & Ueta, Y. (2003) · Hypertension Research · doi:10.1291/hypres.26.s61 · Cited by 45
“It seems probable that CRLR–RAMP-2 and CRLR–RAMP-3 compose functional AM receptors, whereas the identity of both human (59) and rat L1 (57) orphan receptors as AM receptors has been questioned (60).”
BackgroundInfluentialFunctional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system
Yamauchi, A., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Igarashi, K., Toriyama, Y., Tanaka, M., Liu, T., Xian, X., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.017 · Cited by 45
“Using this model, we found that RAMP2 is essential for angiogenesis and vascular Abbreviations:AM, adrenomedullin; CLR, calcitonin receptor-like receptor; RAMP, receptor activity-modifying protein; GPCR, G protein-coupled receptor; CGRP, calcitonin gene-related peptide; DI-VE-RAMP2−/−, drug-inducible vascular endothel…”
Stachniak, T. J. E., & Krukoff, T. L. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01064.x · Cited by 43
Zandawala, M., Li, S., Hauser, F., Grimmelikhuijzen, C. J. P., & Orchard, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082466 · Cited by 43
Poyner, D. R., Taylor, G. M., Tomlinson, A. E., Richardson, A. G., & Smith, D. M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702437 · Cited by 43
“Speci®city is determined by accessory proteins belonging to the RAMP family (receptor activity modifying proteins), with RAMP1 coexpression leading to a CGRP receptor, and RAMP2 coexpression resulting in an adrenomedullin receptor (McLachtie et al., 1998).”
BackgroundPharmacological characterisation of amylin-related peptides activating subfornical organ neurones
Riediger, T., SCHMID, H. A., Young, A. A., & Simon, E. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01697-2 · Cited by 43
Adrenomedullin in the treatment of pulmonary hypertension
Nagaya, N., & Kangawa, K. (2004) · Peptides · doi:10.1016/j.peptides.2004.07.007 · Cited by 43
Farley, J. R., Dimai, H.-P., Stilt-Coffing, B., Farley, P., Pham, T., & Mohan, S. (2000) · Calcified Tissue International · doi:10.1007/s002230001112 · Cited by 48
“However, previous studies have shown: (1) multiple isoforms of the CT receptor, with different affinities [70, 71]; (2) that CT, CGRP, and amylin can bind to (and in some cases, activate) each other’s receptors [68, 69, 72, 73]; and (3) that receptor activity modifying proteins (RAMPs) can modulate the specificity of…”
ResultKnerr, I., Dachert, C., Beinder, E., Metzler, M., Dötsch, J., Repp, R., & Rascher, W. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00519-x · Cited by 43
Molecular and functional characterization of adrenomedullin receptors in pufferfish
Nag, K., Kato, A., Nakada, T., Hoshijima, K., Mistry, A. C., Takei, Y., & Hirose, S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00507.2005 · Cited by 45
“They exert their physiological functions through two members of class B, G protein-coupled receptor (GPCR), namely 1) CT receptor (CTR) and 2) CT receptor-like receptor (CLR) (29) that is associated with a new class of single transmembrane protein termed receptor activity-modifying protein (RAMP) (20).”
BackgroundReduction in Vascular Responsiveness to Adrenomedullin during Sepsis
Wang, P., Yoo, P. S., Zhou, M., Cioffi, W. G., Ba, Z. F., & Chaudry, I. H. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5634 · Cited by 45
Barwell, J., Conner, A. C., & Poyner, D. R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.06.005 · Cited by 42
Sundrum, T., & Walker, C. S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14053 · Cited by 42
“Three RAMPs have been identified, RAMP1, RAMP2 and RAMP3, which have been shown to interact with a subset of GPCRs (McLatchie et al., 1998; Hay et al., 2016; Hay and Pioszak, 2016).”
BackgroundInfluentialSerafín, D., Harris, N. R., Nielsen, N. R., Mackie, D. I., & Caron, K. M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.009 · Cited by 44
“Commonly, these results were validated using a combination of radioligand binding, coimmunoprecipitation and western blot analysis, and interrogation of downstream G-protein signaling [4, 7, 8, 13, 23, 25-27].”
BackgroundMethodInfluentialEffect of Adrenomedullin on the Cerebral Circulation: Relevance to Primary Headache Disorders
Petersen, K. A., Birk, S., Kitamura, K., & Olesen, J. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01695.x · Cited by 43
Takei, Y., Ogoshi, M., & Inoue, K. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.05.001 · Cited by 48
Functional and Biophysical Analysis of the C-Terminus of the CGRP-Receptor; a Family B GPCR
Conner, M. T., Hicks, M. R., Dafforn, T. R., Knowles, T. J., Ludwig, C., Staddon, S. L., Overduin, M., Günther, U. L., Thome, J., Wheatley, M., et al. (2008) · Biochemistry · doi:10.1021/bi8004126 · Cited by 42
Zhang, Z., Dickerson, I. M., & Russo, A. F. (2005) · Endocrinology · doi:10.1210/en.2005-0918 · Cited by 45
Yuyun, M. F., Narayan, H., & Ng, L. L. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.027 · Cited by 51
Regulation of calcium-sensing-receptor trafficking and cell-surface expression by GPCRs and RAMPs
Bouschet, T., Martin, S., & Henley, J. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.002 · Cited by 42
Expression of the adrenomedullin gene in adipose tissue
Nambu, T., Arai, H., Komatsu, Y., Yasoda, A., Moriyama, K., Kanamoto, N., Itoh, H., & Nakao, K. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.07.006 · Cited by 46
Bonner, K., Pease, J. E., Corrigan, C. J., Clark, P., & Kay, A. B. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.015 · Cited by 42
Husmann, K., Born, W., Fischer, J. A., & Muff, R. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.009 · Cited by 42
Springer, J., Amadesi, S., Trevisani, M., Harrison, S., Dinh, Q. T., McGregor, G. P., Fischer, A., Geppetti, P., & Groneberg, D. A. (2003) · Regulatory Peptides · doi:10.1016/j.regpep.2003.11.006 · Cited by 42
“In contrast, the cotransfection of the CL-receptor with the RAMP2 protein leads to the expression of high-affinity receptors for adrenomedullin [19].”
BackgroundPrediction of interfaces for oligomerizations of G‐protein coupled receptors
Nemoto, W., & Toh, H. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20332 · Cited by 44
“can form oligomers not only with GPCRs but also with other membrane proteins.(29,45) For example, carboxylterminal domain of D5R is suggested to interact with the second intracellular loop of the GABAAR.”
BackgroundConcomitant expression of adrenomedullin and its receptor components in rat adipose tissues
Fukai, N., Yoshimoto, T., Sugiyama, T., Ozawa, N., Sato, R., Shichiri, M., & Hirata, Y. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2003 · Cited by 45
“It has been recently revealed that calcitonin receptor-like receptor (CRLR) functions as an AM receptor when receptor activity-modifying protein (RAMP)2 is coexpressed on the cellular membrane (24).”
BackgroundTakahashi, K. (2001) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.193.79 · Cited by 43
Attenuation of antigen-induced airway hyperresponsiveness in CGRP-deficient mice
Aoki‐Nagase, T., Nagase, T., Oh-hashi, Y., Shindo, T., Kurihara, Y., Yamaguchi, Y., Yamamoto, H., Tomita, T., Ohga, E., Nagai, R., et al. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00130.2002 · Cited by 45
“Because CGRP is one of the potent mediators possibly involved in bronchial asthma (39), genes regulating the function of CGRP, calcitonin receptor-like receptor, and RAMP1 could be targets to study the pathogenesis of asthma.”
BackgroundAdrenomedullin is anti‐apoptotic in osteoblasts through CGRP1 receptors and MEK‐ERK pathway
Uzan, B., Villemin, A., Garel, J., & Cressent, M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21294 · Cited by 41
“Expression of CRLR with RAMP1 produces a receptor which preferentially binds CGRP, while expression of CRLR with RAMP2 or RAMP3 forms ADM receptor (McLatchie et al., 1998).”
BackgroundOrphan G protein-coupled receptors: the ongoing search for a home
Jobe, A., & Vijayan, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1349097 · Cited by 44
Nouguerède, E., Berenguer‐Daizé, C., Garcia, S., Bennani, B., Delfino, C., Nanni, I., Dahan, L., Gasmi, M., Seitz, J., Martin, P., et al. (2013) · Cancer Medicine · doi:10.1002/cam4.51 · Cited by 41
“AM binds to and mediates its activity through the G-protein-coupled receptor calcitonin receptor-like receptor (CLR), with specificity for AM being conferred by the receptor activity-modifying protein-2 (RAMP2) and -3 (RAMP3) [8].”
BackgroundRetractedWatkins, H. A., Chakravarthy, M., Abhayawardana, R. S., Gingell, J. J., Garelja, M. L., Pardamwar, M., Mcelhinney, J., Lathbridge, A., Constantine, A., Harris, P. W. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688218 · Cited by 42
“Analysis of Cell Surface Expression of Mutants by ELISA— CLR, RAMP2, and RAMP3 are inefficiently expressed on their own at the cell surface (32).”
MethodOligomerization of GPCRs involved in endocrine regulation
Kleinau, G., Müller, A., & Biebermann, H. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0049 · Cited by 42
Adrenomedullin-RAMP2 System in Vascular Endothelial Cells
Koyama, T., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., & Shindo, T. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29967 · Cited by 42
Maybin, J. A., Battersby, S., Hirani, N., Nikitenko, L. L., Critchley, H., & Jabbour, H. N. (2011) · Endocrinology · doi:10.1210/en.2010-1256 · Cited by 46
“Receptor activity-modifying proteins (RAMP) associate with CLR to determine its ligand binding specificity (18).”
BackgroundMethodEffects of melanocortins on adrenal gland physiology
Chan, L. F., Metherell, L., & Clark, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.041 · Cited by 45
Ventricular Adrenomedullin System in the Transition From LVH to Heart Failure in Rats
Nishikimi, T., Tadokoro, K., Mori, Y., Wang, X., Akimoto, K., Yoshihara, F., Minamino, N., Kangawa, K., & Matsuoka, H. (2003) · Hypertension · doi:10.1161/01.hyp.0000053447.64213.c4 · Cited by 43
Yallampalli, C., Kondapaka, S. B., Lanlua, P., Wimalawansa, S. J., & Gangula, P. R. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.022467 · Cited by 41
“U 17473) and RAMP1 (accession number AJ 001014) were derived using published sequences from the GenBank database [18].”
BackgroundMethodMiller, P. S., Barwell, J., Poyner, D. R., Wigglesworth, M. J., Garland, S. L., & Donnelly, D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.076 · Cited by 43
“Human CLR with an N-terminal hemagglutinin (HA) epitope tag (YPYDVPDYA) [8], was provided by Dr. Foord (GlaxoSmithKline, Stevenage, UK) and was sub-cloned into pcDNA3 (Invitrogen, Renfrew, UK) prior to mutagenesis.”
BackgroundMethodInfluentialBorn, W., Fischer, J. A., & Muff, R. (2002) · Receptors and Channels · doi:10.1080/10606820213683 · Cited by 44
Effect of Adrenomedullin on Placental Arteries in Normal and Preeclamptic Pregnancies
Jerat, S., Morrish, D. W., Davidge, S. T., & Kaufman, S. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.227 · Cited by 44
Amylin inhibits ovariectomy-induced bone loss in rats
Horcajada-Molteni, M., Davicco, M., Lebecque, P., Coxam, V, Young, A., & Barlet, J. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650663 · Cited by 40
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
Walker, C. S., Aitken, J. F., Amarsingh, G. V., Zhang, S., & Cooper, G. J. S. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01125-9 · Cited by 40
“The interactions between a GPCR and RAMPs were first identified for the CLR, where a CGRP receptor is formed by the CLR bound to RAMP1, whereas adre-nomedullin receptors are formed by CLR in combination with RAMP2 or RAMP3, and are called AM 1 and AM 2 receptors, respectively 15,30 .”
Calcitonin receptor isoforms expressed in the developing rat kidney
Tikellis, C., Xuereb, L., CASLEY, D. J., Brasier, G., Cooper, M. E., & Wookey, P. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00754.x · Cited by 42
Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins)
Cismowski, M. J. (2006) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2006.03.003 · Cited by 48
CGRP Receptor Signalling Pathways
Cottrell, G. S. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_130 · Cited by 40
Borroto‐Escuela, D. O., & Fuxé, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00230 · Cited by 42
Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors
Garelja, M. L., Au, M., Brimble, M. A., Gingell, J. J., Hendrikse, E. R., Lovell, A., Prodan, N., Sexton, P. M., Siow, A., Walker, C. S., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00083 · Cited by 41
The role of erenumab in the treatment of migraine
Andreou, A. P., Fuccaro, M., & Lambru, G. (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420927119 · Cited by 40
Martínez‐Martínez, E., Galván-Hernández, C. I., Toscano‐Márquez, B., & Gutiérrez‐Ospina, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036421 · Cited by 42
“It is possible that CLR protein in the bulge could bind CGRP because RAMP-1 protein is also contained in CD34 cells of the bulge [47].”
BackgroundAccessory proteins are vital for the functional expression of certain G protein-coupled receptors
Cooray, S. N., Chan, L. F., Webb, T. R., Metherell, L., & Clark, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.004 · Cited by 45
Role of calcitonin receptor-like receptor in colonic motility and inflammation
Clifton, M. S., Hoy, J. J., Chang, J., Idumalla, P. S., Fakhruddin, H., Grady, E. F., Dada, S. A., Corvera, C. U., & Bhargava, A. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00464.2006 · Cited by 40
The expanding repertoire of receptor activity modifying protein (RAMP) function
Klein, K. R., Matson, B. C., & Caron, K. M. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1128875 · Cited by 40
“Studies using RAMP chimeras that exchanged RAMP domains concluded that the N-terminus determines ligand specificity, while the C-terminus modifies downstream signaling for CLR- and CTR-based receptors (Fraser et al., 1999; Udawela et al., 2006).”
BackgroundMethodInfluentialVoisin, T., Goumain, M., Lorinet, A.-M., Maoret, J.-J., & Laburthe, M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35334-0 · Cited by 40
Nussdorfer, G. G. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)06024-7 · Cited by 40
Sex Differences in CGRP Regulation and Function in the Amygdala in a Rat Model of Neuropathic Pain
Presto, P., & Neugebauer, V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.928587 · Cited by 41
Paracrine control of vascular innervation in health and disease
Storkebaum, E., & Carmeliet, P. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02333.x · Cited by 44
“In this receptor complex, RAMP1 is required to transport CRLR to the plasma membrane and also controls the glycosylation pattern of CRLR, converting it into a CGRP receptor.”
BackgroundInfluentialYamauchi, A., Kamiyoshi, A., Koyama, T., Iinuma, N., Yamaguchi, S., Miyazaki, H., Hirano, E., Kaku, T., & Shindo, T. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00416 · Cited by 40
“Adrenomedullin is an endogenous vasoprotective peptide produced primarily by vascular endothelial cells (Kitamura et al., 1993), and RAMP2 is its receptor modulating protein (McLatchie et al., 1998).”
BackgroundVázquez, R., Riveiro, M. E., Berenguer‐Daizé, C., O’Kane, A. A., Gormley, J. A., Touzelet, O., Rezaï, K., Békradda, M., & Ouafik, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.589218 · Cited by 41
“Although further studies have not confirmed this (86, 97), the suggestion that RDC1 and GPR182 may be AM receptors persist to this day.”
BackgroundResultMeyrath, M., Palmer, C. B., Reynders, N., Vanderplasschen, A. F. C., Ollert, M. W., Bouvier, M., Szpakowska, M., & Chevigné, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00006 · Cited by 40
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.